Global Drug Infusion Systems Market

Focus on Products, Application, Competitive Landscape and 57 Countries - Analysis and Forecast (2017-2025)

Published Year: 2018
SKU: BH00560SA

4599

Online Access for One Person. Permission to Print

A quick peek into the report

Market Overview

The global drug infusion systems market was estimated to be $8.1 billion in 2016 and is estimated to grow over $14.7 billion by 20

The increased prevalence of chronic diseases and the rising geriatric population has led to the high demand for better medicines and facilities. As per the Arthritis Foundation, the older population in the U.S. affected by arthritis is estimated to grow to 21% by 2040, from the current value of 15%.  The rising prevalence of chronic diseases is another factor contributing to the growth of the market. In the recent years, the prevalence of chronic diseases has been increasing irrespective of the age.  As per the World Health Organization (WHO), the global prevalence of diabetes increased to 8.5% in adults over the age of 18 years in 2014 from 4.7% in 1980. The prevalence of genetic diseases, and cancer has also witnessed a rise in the recent years. For the continued and improved care of the patients, the drug infusion systems are being extensively used in the hospitals as well as the home care settings. The U.S. FDA defines an infusion system as a medical device that delivers controlled amounts of fluids such as nutrients and medication. 

The purpose of the study is to gain a holistic view of the drug infusion systems market in terms of various factors influencing it such as recent trends, technological advancements, and regulatory aspects of the market. The scope of this report is centred upon conducting a detailed study of the solutions allied with the drug infusion systems market. The market has been segmented into ‘product’, ‘end-users’, ‘application’ and ‘geographical regions’. 

The global drug infusion systems market was estimated to be $8.1 billion in 2016 and is estimated to grow over $14.7 billion by 2025. The rise in the geriatric population along with the increased prevalence of chronic diseases is expected to boost the demand for drug infusion systems and drive the global market towards rapid growth. The drug infusion systems market presents with opportunities to change the treatment options according to the needs of the patient.

The global drug infusion systems market can be segmented on the basis of product into large volume pumps, enteral pumps, Patient Controlled Analgesia (PCA) pumps, syringe pumps, insulin pumps, ambulatory pumps, implantable and others. The major contributor towards the market in 2016 was the large volume pump systems. Based on the application type, the market is segmented into diabetes, oncology, analgesia, nutrition, haematology, paediatrics, and others. 

On the basis of end users the market can be segmented into hospitals, homecare, ambulatory surgical centres and others. The market for the home care is expected to reach $1,457.1 million by 2025. Based on the regional segmentation, the largest contributor to the growth of the global drug infusion systems market in 2016 was  North America due to the presence of positive government regulations and reimbursement policies apart from the rising elderly population followed by Europe. The highest CAGR was estimated for the Asia-pacific region because of rising healthcare expenditure and increasing patient awareness.

Drug infusion systems provide safe, accurate and precise drug delivery. The market is expected to grow in future due to technological advancements, higher demand in the developing nations, and increased usage across different therapeutic indication. 

The report provides in-depth SWOT analysis of different key players of the market, supported by extensive financial summary of each. The key players for the market are Becton, Dickinson & Company, Caesarea Medical Electronics Ltd, Debiotech, Medtronic, Flowonix Medical Inc., Fresenius SE & Co. KGaA, ICU Medical, Insulet Corporation, IRADIMED CORPORATION, MOOG, Smiths Group, Tandem Diabetes care, and Terumo Corporation, among others.

Key Questions Answered in this Report:

What are the major market drivers, challenges, and opportunities in the global drug infusion systems market?

•    What are the major market drivers, challenges, and opportunities in the global drug infusion systems market?
•    How did the drug infusion systems market evolve, and what is its scope in the future?
•    What is the market share of the leading segments, and sub-segments of the global drug infusion systems market in the period 2016-2025?
•    How will each segment of the global drug infusion systems market grow during the forecast period, and what will be the revenue generated by each of the segments by the end of 2025?
•    What are the influencing factors that may affect the market share of the key players?
•    What are the key developmental strategies implemented by the key players to stand out in this market?
•    What is the infusion systems market value in different countries of the world?
•    What will be the growth rate of the insulin infusion systems during the forecast period?
•    Which product segment is expected to register the highest CAGR for the drug infusion systems market?
•    How has the market been segmented on the basis of application? Which application segment has the largest share, and growth rate in the drug infusion systems market?
•    How the homecare segment among the end users will grow in the period 2016-2025?
•    Which geographical region will contribute to the highest sales of drug infusion systems?

Report Description

The purpose of the study is to gain a holistic view of the drug infusion systems market in terms of various factors influencing it

The increased prevalence of chronic diseases and the rising geriatric population has led to the high demand for better medicines and facilities. For the continued and improved care of the patients, the drug infusion systems are being extensively used in the hospitals as well as the home care settings.

As per the Arthritis Foundation, the older population in the U.S. affected by arthritis is estimated to grow to 21% by 2040, from the current value of 15%. The rising prevalence of chronic diseases is another factor contributing to the growth of the market. In the recent years, the prevalence of chronic diseases has been increasing irrespective of the age. As per the World Health Organization (WHO), the global prevalence of diabetes increased to 8.5% in adults over the age of 18 years in 2014 from 4.7% in 1980. The prevalence of genetic diseases, and cancer has also witnessed a rise in the recent years.

As per the U.S. FDA an infusion pump is a medical device that delivers controlled amounts of fluids such as nutrients and medication. 

The drug infusion systems market includes various infusion systems products including the components such as pumps, accessories and disposables. The market includes several products such as large volume pumps, enteral pumps, syringe pumps, insulin pumps, elastomeric pumps, Patient controlled Analgesia (PCA), ambulatory pumps, and implantable pumps, among many others. These devices are being used for the administration of fluids and medication to a number of diseases, and therapeutic areas such as diabetes, analgesia, nutrition, haematology, oncology and paediatrics. The market analysis includes an in-depth examination of the key ecosystem players, and the key strategies and developments taking place in this market. Additionally, it includes market dynamics (market drivers, opportunities, and challenges), and industry analysis. 

The purpose of the study is to gain a holistic view of the drug infusion systems market in terms of various factors influencing it such as recent trends, technological advancements, and regulatory aspects of the market. The scope of this report is centred upon conducting a detailed study of the solutions allied with the drug infusion systems market. The market has been segmented into ‘product’, ‘application’, ‘end users’ and ‘geographical regions’. The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market, and helps in forming well informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into the consideration before entering the market.

This research report aims at answering various aspects of the global market with the help of the key factors driving the market, threats that can possibly inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion. The study considers the growth-share matrix model for a comprehensive study of the global drug infusion systems market, and assesses the factors governing the same.

The key players that have been contributing significantly to the drug infusion systems market are Becton, Dickinson & Company, Caesarea Medical Electronics Ltd, Debiotech, Medtronic, Flowonix Medical Inc., Fresenius SE & Co. KGaA, ICU Medical, Insulet Corporation, IRADIMED CORPORATION, MOOG, Smiths Group, Tandem Diabetes care, and Terumo Corporation, among others.

Table of Contents

1 Market Overview

1.1.    Introduction
1.2.    Definition and Characterization
1.3.    Infusion Systems Application
1.4.    Market Size and Growth Potential
1.5.    Technology Advancements
1.6.    Pricing Analysis
1.7.    Recent Product Launches

2 Market Dynamics

2.1.    Market Drivers
2.2.    Market Challenges
2.3.    Market Opportunities

3 Industry Insights

3.1.    Regulatory Scenario
3.2.    Patent Landscape

4 Competitive Landscape

4.1.    Share of Different Strategies
4.2.    Porter's Five Force Analysis
4.3.    Market Share Analysis

5 Global Drug Infusion Systems Market, By Product

5.1.    Introduction & Different Components of a Drug Infusion System
5.2.    Market Segment
5.3.    Large Volume Infusion Systems
5.4.    Patient Controlled Analgesia
5.5.    Elastomeric Infusion Pumps
5.6.    Insulin Infusion Pumps
5.7.    Syringe Infusion Systems
5.8.    Implantable Infusion Systems
5.9.    Ambulatory Infusion Systems
5.10.    Enteral Infusion Systems

6 Global Drug Infusion Systems Market, by Application

6.1.    Introduction
6.2.     Oncology/Chemotherapy
6.3.    Diabetes
6.4.    Analgesia
6.5.    Nutrition
6.6.    Haematology
6.7.    Paediatrics
6.8.    Other Applications

7 Global Drug Infusion Systems Market, By End User

7.1.    Introduction
7.2.    Different Types of End Users

8 Global Drug Infusion Systems Market, By Region

8.1.    Introduction
8.2.    North America
          8.2.1.    The U.S.
          8.2.2.    Canada
8.3.    Europe
          8.3.1.    Austria
          8.3.2.    Belarus
          8.3.3.    Belgium
          8.3.4.    Denmark
          8.3.5.    Finland
          8.3.6.    France
          8.3.7.    Germany
          8.3.8.    Greece
          8.3.9.    Hungary
          8.3.10.    Ireland
          8.3.11.    Italy
          8.3.12.    Luxembourg
          8.3.13.    Netherlands
          8.3.14    Norway
          8.3.15.    Poland
          8.3.16.    Portugal
          8.3.17.    Russia
          8.3.18.    Spain
          8.3.19.    Sweden
          8.3.20    Switzerland
          8.3.21.    Turkey
          8.3.22.    Ukraine
          8.3.23.    The U.K.
8.4.    Asia Pacific
          8.4.1.    Australia
          8.4.2.    Bangladesh
          8.4.3.    China
          8.4.4.    Hong Kong
          8.4.5.    India
          8.4.6.    Indonesia
          8.4.7.    Japan
          8.4.8.    South Korea
          8.4.9.    Malaysia
          8.4.10.    New Zealand
          8.4.11.    Pakistan
          8.4.12.    Philippines
          8.4.13.    Singapore
          8.4.14.    Taiwan
          8.4.15.    Thailand
          8.4.16.    Vietnam
8.5.    Latin America & Middle East & Africa
          8.5.1.    Argentina
          8.5.2.    Brazil
          8.5.3.    Chile
          8.5.4.    Colombia
          8.5.5.    Mexico
          8.5.6.    Egypt
          8.5.7.    Iran
          8.5.8.    Israel
          8.5.9.    Kenya
          8.5.10.    Kuwait
          8.5.11.    Nigeria
          8.5.12.    Oman
          8.5.13.    Qatar
          8.5.14.    Saudi Arabia
          8.5.15.    South Africa
          8.5.16.    United Arab Emirates

9 Company Profiles

9.1.    Acromed AG
9.1.1.    Overview
9.1.2.    Acromed AG: Corporate Summary
9.1.3.    Acromed AG: Product Portfolio
9.1.4.    Acromed AG: SWOT Analysis
9.2.    B. Braun Melsungen AG
9.2.1.    Overview
9.2.2.    B. Braun Melsungen AG: Overall Product Portfolio
9.2.3.    Financials
9.2.3.1.    Financial Summary
9.2.4.    Global Presence
9.2.5.    Recent Developments
9.2.6.    B.Braun Melsungen AG: SWOT Analysis
9.3.     Baxter International Inc.
9.3.1.    Overview
9.3.2.    Baxter International Inc.: Product Portfolio
9.3.3.    Financials
9.3.3.1    Financial Summary
9.3.4.    Global Presence
9.3.5.    Recent Developments
9.3.6.    Baxter International Inc.: SWOT Analysis
9.4.     Becton, Dickinson and Company
9.4.1.    Overview
9.4.2.    Becton, Dickinson and Company: Product Portfolio
9.4.3.    Financials
9.4.3.1    Financial Summary
9.4.4.    Global Presence
9.4.5.    Recent Development
9.4.6.    Becton, Dickinson  and Company: SWOT Analysis
9.5.    Caesarea Medical Electronics Ltd.
9.5.1.    Overview
9.5.2.    Corporate Summary
9.5.3.    Caesarea Medical Electronics Ltd.: Product Portfolio
9.5.4.    Caesarea Medical Electronics: SWOT Analysis
9.6.    Debiotech S.A.
9.6.1.    Overview
9.6.2    Corporate Summary & Product Portfolio
9.6.3.    Debiotech S.A.: SWOT Analysis
9.7.    Flowonix Medical Inc.
9.7.1.    Overview
9.7.2.    Corporate Summary & Product Portfolio
9.7.3.    Recent Developments
9.7.4.    Flowonix Medical Inc.: SWOT Analysis
9.8.    Fresenius SE & Co. KGaA
9.8.1.    Overview
9.8.2.    Fresenius Kabi: Product Portfolio
9.8.3.    Financials
9.8.3.1.    Financial Summary
9.8.4.    Global Presence
9.8.5.    Recent Developments
9.8.6.    Fresenius SE & Co. KGaA: SWOT Analysis
9.9.    Halyard Health, Inc.
9.9.1.    Overview
9.9.2.    Halyard Health,Inc.: Overall Product Portfolio
9.9.3.    Financials
9.9.3.1.    Financial Summary
9.9.4.    Global Presence
9.9.5.    Halyard Health, Inc.: SWOT Analysis
9.10.    ICU Medical Inc.
9.10.1.    Overview
9.10.2.    ICU Medical Inc.: Product Portfolio
9.10.3.    Financials
9.10.3.1.    Financial Summary
9.10.4.    Global Presence
9.10.5.    Recent Developments
9.10.6.    ICU Medical Inc.: SWOT Analysis
9.11.    IRADIMED CORPORATION
9.11.1.    Overview
9.11.2.    IRADIMED CORPORATION: Product Portfolio
9.11.3.    Financials
9.11.3.1    Financial Summary
9.11.4.    Global Presence
9.11.5.    Recent Developments
9.11.6.    IRADIMED CORPORATION: SWOT Analysis
9.12.    Insulet Corporation
9.12.1.    Overview
9.12.2.    Insulet Corporation: Product Portfolio
9.12.3.    Financials
10.12.3.1.    Financial Summary
9.12.4.    Global Presence
9.12.5.    Recent Developments
9.12.6.    Insulet Corporation: SWOT Analysis
9.13.    Medtronic Public Limited Company
9.13.1.    Overview
9.13.2.    Medtronic Public Limited Company: Product Portfolio
9.13.3.    Financials
9.13.3.1.    Financial Summary
9.13.4.    Global Presence
9.13.5.    Medtronic Public Limited Company: SWOT Analysis
9.14.    MOOG, Inc.
9.14.1.    Overview
9.14.2.    MOOG, Inc.: Product Portfolio
9.14.3.    Financials
9.14.3.1.    Financial Summary
9.14.4.    Global Presence
9.14.5.    Recent Developments
9.14.6.    MOOG, Inc.: SWOT Analysis
9.15.    Smiths Group plc
9.15.1.    Overview
9.15.2.    Smiths Group plc: Product Portfolio
9.15.3.    Financials
9.15.3.1.    Financial Summary
9.15.4.    Global Presence
9.15.5.    Recent Developments
9.15.6.    Smiths Group plc: SWOT Analysis
9.16.    Tandem Diabetes Care, Inc.
9.16.1.    Overview
9.16.2.    Tandem Diabetes Care, Inc.: Product Portfolio
9.16.3.    Financials
9.16.3.1.    Financial Summary
9.16.4.    Global Presence
9.16.5.    Recent Developments
9.16.6.    Tandem Diabetes Care, Inc.: SWOT Analysis
9.17.    Terumo Corporation
9.17.1.    Overview
9.17.2.    Terumo corporation: Product Portfolio
9.17.3.    Financials
9.17.3.1.    Financial Summary
9.17.4.    Global Presence
9.17.5.    Terumo Corporation: SWOT Analysis
9.18.    Zyno Medical, LLC
9.18.1.    Overview
9.18.2.    Corporate Summary 
9.18.3.    Zyno Medical, LLC: Product Portfolio
9.18.4.    Recent Developments
9.18.5.    Zyno Medical, LLC: SWOT Analysis
9.19.    Snapshot of Other Key Players: Ivenix, Inc.

10 Report Scope

10.10.1.    Scope of the Report
10.10.2.    Global Drug Infusion Systems Market Segmentation
10.10.3.    Research Methodology
                 10.10.3.1.    Primary Research
                 10.10.3.2.    Secondary Research
                 10.10.3.3.    Key Data Points From Primary Sources
                 10.10.3.4.    Key Data Points From Secondary Sources
                 10.10.3.5.    Data Triangulation
                 10.10.3.6.    Top-Down Approach (Segmental Analysis)
                 10.10.3.7.    Bottom-Up Approach (Segmental Analysis)
10.10.4.    Assumptions & Limitations

List of Tables

1    Drug Infusion Systems Market, The U.S. vs China
2    Recent Product Launches
3    Global Regulatory Scenario
4    Patent Landscape
5    Examples of Marketed Large Volume Infusion Pumps
6    Examples of Marketed PCA Pumps
7    Examples of Marketed Syringe Infusion Systems
8    Global Infusion Pumps Market, by Country 2016-2025 ($Million)
9    Global Infusion Disposables Market, by Country 2016-2025 ($Million)
10    Global Infusion Accessories Market, by Country 2016-2025 ($Million)
11    Percentages of Population Aged 60 Years and Above
12    Arcomed AG: Overview
13    B. Braun Melsungen AG: Overview
14    B. Braun Melsungen AG: Recent Developments
15    Baxter International: Overview
16    Baxter International: Product Developments
17    Baxter International: Awards & Recognition
18    Becton, Dickinson and Company: Overview
19    Becton, Dickinson and Company: Product Development
20    Caesarea Medical Electronics Ltd.: Overview
21    Debiotech S.A.: Overview
22    Flowonix Medical Inc.: Overview
23    Flowonix Medical Inc.: Product Development
24    Fresenius SE & Co. KGaA: Overview
25    Fresenius SE & Co. KGaA: Recent Developments
26    Halyard Health, Inc.: Overview
27    ICU Medical Inc.: Overview
28    ICU Medical Inc.: Recent Developments
29    IRADIMED CORPORATION: Overview
30    IRADIMED CORPORATION: Recent Development
31    Insulet Corporation: Overview
32    Insulet Corporation: Acquisitions, Collaborations, and Agreements
33    Medtronic Public Limited Company: Overview
32    MOOG, Inc.: Overview
33    MOOG, Inc.: Product Developments
34    Smiths Group plc: Overview
35    Smiths Group plc: Recent Developments
36    Tandem Diabetes Care, Inc.: Overview
37    Tandem Diabetes Care, Inc.: Recent Developments
38    Terumo Corporation: Overview
39    ZynoMedical, LLC: Overview
40    Zyno Medical, LLC: Recent Developments
41    Ivenix, Inc.: Overview

List of Figures

1    Chronic Conditions: Key Statistics: 2016
2    Market Drivers and Challenges
3    Global Drug Infusion Systems Market, by Components, 2016
4    Global Drug Infusion Systems Market, by Components, 2025
5    Global Drug Infusion Systems Market, by Infusion System Type, 2016
6    Global Drug Infusion Systems Market, by Infusion System Type, 2025
7    Global Drug Infusion Systems Market, by Application, 2016
8    Global Drug Infusion Systems Market, by Application, 2025
9    Global Drug Infusion Systems Market, by End User, 2016
10    Global Drug Infusion Systems Market, by End User, 2025
11    Global Drug Infusion Systems Market, by Region, 2016
12    Global Drug Infusion Systems Market, by Region, 2025
13    Global Drug Infusion Systems Market
14    Market Share Analysis
15    Advantages of Drug Infusion Systems
16    Desirable Characteristics of Drug Infusion Systems
17    Global Drug Infusion Systems Market Size & Growth Potential, by Product Type
18    Global Drug Infusion Systems Market Size & Growth Potential, by End User
19    Global Drug Infusion Systems Market Size & Growth Potential, by Application
20    Number of People with Chronic Conditions (U.S.) in Million
21    Infusion Pump Recalls, 2010-2017
22    Per Day Cost Savings vs. Hospitals
23    Share of Different Strategies
24    Porter's Five Forces Analysis
25    Market Share Analysis
26    Components of Drug Infusion Systems
27    Global Drug Infusion Systems Market, by Components
28    Segmentation of Global Drug Infusion Systems Market, By Product
29    Global Drug Infusion Systems Market, by Product, 2016-2025 ($Million)
30    Global Large Volume Infusion Systems Market, 2016-2025 ($Million)
31    Global PCA Infusion Systems Market, 2016-2025 ($Million)
32    Global Elastomeric Infusion Systems Market, 2016-2025 ($Million)
33    Global Insulin Infusion Systems Market, 2016-2025 ($Million)
34    Global Syringe Infusion Systems Market, 2016-2025 ($Million)
35    Global Implantable Infusion Systems Market, 2016-2025 ($Million)
36    Advantages & Disadvantages of Implantable Infusion Systems
37    Global Ambulatory Infusion Systems Market, 2016-2025 ($Million)
38    Global Enteral Infusion Systems Market, 2016-2025 ($Million)
39    Applications of Infusion Systems
40    Global Drug Infusion Systems Market, by Application, 2016-2025 ($Million)
41    Global Oncology Infusion Systems Market, 2016-2025, ($Million)
42    Number of New Cancer Cases
43    Types of Diabetes Mellitus
44    Global Patients Diagnosed with Diabetes
45    Global Diabetes Infusion Systems Market, 2016-2025, ($Million)
46    Global Analgesia Infusion Systems Market, 2016-2025, ($Million)
47    Most Common Types of Chronic Pain
48    Global Nutrition Infusion Systems Market, 2016-2025, ($Million)
49    Global Haematology Infusion Systems Market, 2016-2025, ($Million)
50    Global Paediatrics Infusion Systems Market, 2016-2025, ($Million)
51    Global Others Infusion Systems Market, 2016-2025, ($Million)
52    Global Drug Infusion Systems Market, End User
53    Global Drug Infusion Systems Market, by End User, 2016-2025 ($Million)
54    Global Drug Infusion Systems Market, by Region, 2016-2025 ($million)
55    North America Drug Infusion Systems Market 2016-2025 ($Million)
56    North America Drug Infusion Systems Market, by Components 2016-2025 ($Million)
57    The U.S. Drug Infusion Systems Market, by Value, 2016-2025 ($million)
58    The U.S. Drug Infusion Systems Market, by Type 2016-2025($million)
59    Canadian Drug Infusion Systems Market, by Value, 2016-2025 ($million)
60    Canadian Drug Infusion Pumps Market, by Type 2016-2025($million)
61    European Drug Infusion Systems Market,2016-2025 ($Million)
62    European Drug Infusion Systems Market, by Components, 2016-2025 ($Million)
63    Austria Drug Infusion Pumps Market, by value, 2016-2025 ($million)
64    Austria Drug Infusion Pumps Market, by type 2016-2025($million)
65    Belarus Drug Infusion Systems Market, by value, 2016-2025 ($million)
66    Belarus Drug Infusion Pumps Market, by type 2016-2025($million)
67    Belgium Drug Infusion Systems Market, by value, 2016-2025 ($million)
68    Belgium Drug Infusion Systems Market, by type 2016-2025
69    Denmark Drug Infusion Systems Market, by value, 2016-2025 ($million)
70    Denmark Drug Infusion Systems Market, by type 2016-2025
71    Finland Drug Infusion Systems Market, by value, 2016-2025 ($million)
72    Finland Drug Infusion Systems Market, by type 2016-2025 ($million)
73    France Drug Infusion Systems Market, by value, 2016-2025 ($million)
74    France Drug Infusion Pumps Market, by volume 2016-2025 ($million)
75    Germany Drug Infusion Pumps Market, by value, 2016-2025 ($million)
76    Germany Drug Infusion Pumps Market, by type 2016-2025 ($million)
77    Greece Drug Infusion Systems Market, by value, 2016-2025 ($million)
78    Greece Drug Infusion Systems Market, by type 2016-2025 ($million)
79    Hungary Drug Infusion Systems Market, by value, 2016-2025 ($million)
80    Hungary Drug Infusion Systems Market, by type 2016-2025 ($million)
81    Ireland Drug Infusion Systems Market, by value, 2016-2025 ($million)
82    Ireland Drug Infusion Systems Market, by type 2016-2025 ($million)
83    Italy Drug Infusion Systems Market, by value, 2016-2025 ($million)
84    Italy Drug Infusion Systems Market, by type 2016-2025 ($million)
85    Luxembourg Drug Infusion Systems Market, by value, 2016-2025 ($million)
86    Luxembourg Drug Infusion Systems Market, by type 2016-2025 ($million)
87    Netherlands Drug Infusion Systems Market, by value, 2016-2025 ($million)
88    Netherlands Drug Infusion Systems Market, by type 2016-2025 ($million)
89    Norway Drug Infusion Systems Market, by value, 2016-2025 ($million)
90    Norway Drug Infusion Systems Market, by type 2016-2025 ($million)
91    Poland Drug Infusion Systems Market, by value, 2016-2025 ($million)
92    Poland Drug Infusion Systems Market, by type 2016-2025 ($million)
93    Portugal Drug Infusion Systems Market, by value, 2016-2025 ($million)
94    Portugal Drug Infusion Systems Market, by type 2016-2025 ($million)
95    Russia Drug Infusion Systems Market, by value, 2016-2025 ($million)
96    Russia Drug Infusion Systems Market, by type 2016-2025 ($million)
97    Spain Drug Infusion Systems Market, by value, 2016-2025 ($million)
98    Spain Drug Infusion Systems Market, by type 2016-2025 ($million)
99    Sweden Drug Infusion Pumps Market, by value, 2016-2025 ($million)
100    Sweden Drug Infusion Pumps Market, by type 2016-2025 ($million)
101    Switzerland Drug Infusion Systems Market, by value, 2016-2025 ($million)
102    Switzerland Drug Infusion Systems Market, by type 2016-2025 ($million)
103    Turkey Drug Infusion Systems Market, by value, 2016-2025 ($million)
104    Turkey Drug Infusion Systems Market, by type 2016-2025 ($million)
105    Ukraine Drug Infusion Systems Market, by value, 2016-2025 ($million)
106    Ukraine Drug Infusion Systems Market, by type 2016-2025 ($million)
107    The U.K. Drug Infusion Systems Market, by value, 2016-2025 ($million)
108    The U.K. Drug Infusion Systems Market, by type 2016-2025 ($million)
109    Asia Pacific Drug Infusion Systems Market, 2016-2025, ($Million)
110    Asia Pacific Drug Infusion Systems Market, by Component, 2016-2025 ($Million)
111    Australian Drug Infusion Systems Market, by value, 2016-2025 ($million)
112    Australian Drug Infusion Systems Market, by type 2016-2025 ($million)
113    Asia Pacific Drug Infusion Systems Market, by Component, 2016-2025 ($Million)
114    Australian Drug Infusion Systems Market, by value, 2016-2025 ($million)
115    Australian Drug Infusion Systems Market, by type 2016-2025 ($million)
116    Bangladesh Drug Infusion Systems Market, by value, 2016-2025 ($million)
117    Bangladesh Drug Infusion Pumps Market, by type 2016-2025 ($million)
118    China Drug Infusion Pumps Market, by value, 2016-2025 ($million)
119    China Drug Infusion Systems Market, by type 2016-2025 ($million)
120    Hong Kong Drug Infusion Systems Market, by value, 2016-2025 ($million)
121    Hong Kong Drug Infusion Systems Market, by type 2016-2025 ($million)
122    India Drug Infusion Systems Market, by value, 2016-2025 ($million)
123    India Drug Infusion Systems Market, by type 2016-2025 ($million)
124    Indonesia Drug Infusion Systems Market, by value, 2016-2025 ($million)
125    Indonesia Drug Infusion Systems Market, by type 2016-2025 ($million)
126    Japan Drug Infusion Pumps Market, by value, 2016-2025 ($million)
127    Japan Drug Infusion Systems Market, by type 2016-2025($million)
128    South Korea Drug Infusion Pumps Market, by value, 2016-2025 ($million)
129    South Korea Drug Infusion Systems Market, by type 2016-2025 ($million)
130    Malaysia Drug Infusion Systems Market, by value, 2016-2025 ($million)
131    Malaysia Drug Infusion Systems Market, by type 2016-2025 ($million)
132    New Zealand Drug Infusion Systems Market, by value, 2016-2025 ($million)
133    New Zealand Drug Infusion Systems Market, by type 2016-2025 ($million)
134    Pakistan Drug Infusion Systems Market, by value, 2016-2025 ($million)
135    Pakistan Drug Infusion Systems Market, by type 2016-2025 ($million)
136    Philippines Drug Infusion Systems Market, by value, 2016-2025 ($million)
137    Philippines Drug Infusion Systems Market, by type 2016-2025 ($million)
138    Singapore Drug Infusion Systems Market, by value, 2016-2025 ($million)
139    Singapore Drug Infusion Systems Market, by type 2016-2025 ($million)
140    Taiwan Drug Infusion Systems Market, by value, 2016-2025 ($million)
141    Taiwan Drug Infusion Systems Market, by type 2016-2025 ($million)
142    Thailand Drug Infusion Systems Market, by value, 2016-2025 ($million)
143    Thailand Drug Infusion Systems Market, by type 2016-2025 ($million)
144    Vietnam Drug Infusion Systems Market, by value, 2016-2025 ($million)
145    Vietnam Drug Infusion Systems Market, by type 2016-2025 ($million)
146    Latin America Drug Infusion Systems Market, 2016-2025 ($million)
147    Latin America Drug Infusion Systems Market, by Components 2016-2025 ($million)
148    Argentina Drug Infusion Pumps Market, by value, 2016-2025 ($million)
149    Argentina Drug Infusion Pumps Market, by type 2016-2025 ($million)
150    Brazil Drug Infusion Systems Market, by value, 2016-2025 ($million)
151    Brazil Drug Infusion Systems Market, by type 2016-2025 ($million)
152    Chile Drug Infusion Systems Market, by value, 2016-2025 ($million)
153    Chile Drug Infusion Pumps Market, by type 2016-2025 ($million)
154    Colombia Drug Infusion Systems Market, by value, 2016-2025 ($million)
155    Colombia Drug Infusion Systems Market, by type 2016-2025 ($million)
156    Mexico Drug Infusion Systems Market, by value, 2016-2025 ($million)
157    Mexico Drug Infusion Systems Market, by type 2016-2025 ($million)
158    MEA Drug Infusion Systems Market, 2016-2025 ($million)
159    MEA Drug Infusion Systems Market, by Component 2016-2025 ($million)
160    Egypt Drug Infusion Systems Market, by value, 2016-2025 ($million)
161    Egypt Drug Infusion Systems Market, by type, 2016-2025 ($million)
162    Iran Drug Infusion Pumps Market, by value, 2016-2025 ($million)
163    Iran Drug Infusion Pumps Market, by type, 2016-2025 ($million)
164    Israel Drug Infusion Systems Market, by value, 2016-2025 ($million)
165    Israel Drug Infusion Systems Market, by type 2016-2025
166    Kenya Drug Infusion Systems Market, by value, 2016-2025 ($million)
167    Kenya Drug Infusion Systems Market, by type, 2016-2025 ($million)
168    Kuwait Drug Infusion Systems Market, by value, 2016-2025 ($million)
169    Kuwait Drug Infusion Systems Market, by type 2016-2025 ($million)
170    Nigeria Drug Infusion Systems Market, by value, 2016-2025 ($million)
171    Nigeria Drug Infusion Pumps Market, by type, 2016-2025 ($million)
172    Oman Drug Infusion Systems Market, by value, 2016-2025 ($million)
173    Oman Drug Infusion Systems Market, by type, 2016-2025 ($million)
174    Qatar Drug Infusion Systems Market, by value, 2016-2025 ($million)
175    Qatar Drug Infusion Systems Market, by type 2016-2025 ($million)
176    Saudi Arabia Drug Infusion Systems Market, by value, 2016-2025 ($million)
177    Saudi Arabia Drug Infusion Systems Market, by type 2016-2025 ($million)
178    South Africa Drug Infusion Pumps Market, by value, 2016-2025 ($million)
179    South Africa Drug Infusion Systems Market, by type 2016-2025 ($million)
180    United Arab Emirates Drug Infusion Systems Market, by value, 2016-2025 ($million)
181    United Arab Emirates Drug Infusion Pumps Market, by type 2016-2025 ($million)
182    Arcomed AG: Overall Product Portfolio
183    Arcomed AG: Product Portfolio of Drug Infusion Systems
184    Arcomed AG: SWOT Analysis
185    B.Braun Melsungen AG: Overall Product Portfolio
186    B.Braun Melsungen AG: Product Portfolio of Drug Infusion Systems
187    B. Braun Melsungen AG: Overall Financials (2014-2016)
188    B. Braun Melsungen AG: Net Revenue by Region (2014-2016)
189    B. Braun Melsungen AG: Revenue by Division (2014-2016)
190    B.Braun Melsungen AG:Global Presence
191    B. Braun Melsungen AG: SWOT Analysis
192    Baxter International Inc.: Overall Product Portfolio
193    Baxter International Inc. : Product Portfolio of Drug Infusion Systems
194    Baxter International Inc.: Overall Financials (2014-2016)
195    Baxter International Inc.: Net Revenue by Region (2014-2016)
196    Baxter International Inc.: Revenue by Segment (2014-2016)
197    Baxter International Inc.: Revenue By Hospital Products Sub-Segment (2014-2016)
198    Baxter International Inc: Global Presence
199    Baxter International Inc.: SWOT Analysis
200    Becton, Dickinson and Company: Overall Product Portfolio
201    Becton, Dickinson and Company: Overall Financials (2015-2017)
202    Becton, Dickinson and Company: Net Revenue by Region (2015-2017)
203    Becton, Dickinson and Company: Revenue by Business Segment (2015-2017)
204    Becton, Dickinson and Company: Revenue by Sub-Segment (2015-2017)
205    Becton, Dickinson and Company: Global Presence
206    Becton, Dickinson and Company: SWOT Analysis
207    Caesarea Medical Electronics Ltd.: Overall Product Portfolio
208    Caesarea Medical Electronics Ltd.: Product Portfolio
209    Caesarea Medical Electronics Ltd.: SWOT Analysis
210    Debiotech S.A.: Overall Product Portfolio
211    Product Portfolio for Debiotech Technologies Segment
212    Debiotech S.A.: SWOT Analysis
213    Flowonix Medical Inc.: Overall Product Portfolio
214    Flowonix Medical Inc.: Drug Infusion Systems Product Portfolio
215    Flowonix Medical Inc.: SWOT Analysis
216    Fresenius SE & Co. KGaA: Overall Product Portfolio
217    Product Portfolio for Fresenius Kabi
218    Fresenius SE & Co. KGaA: Overall Financials (2014-2016)
219    Fresenius Kabi: Revenue by Region (2014-2016)
220    Fresenius SE & Co. KGaA: Revenue by Segment (2014-2016)
221    Fresenius SE & Co. KGaA: Revenue by Sub-Segment (2014-2016)
222    Fresenius SE & Co. KGaA: Global Presence
223    Fresenius SE & Co. KGaA: SWOT Analysis
224    Halyard Health, Inc.: Overall Product Portfolio
225    Halyard Health, Inc.: Drug Infusion Systems Product Portfolio
226    Halyard Health, Inc.: Overall Financials (2014-2016)
227    Halyard Health, Inc.: Revenue by Region (2015-2017)
228    Halyard Health, Inc.: Revenue by Business Segment (2015-2017)
229    Halyard Health, Inc.: Global Presence
230    Halyard Health, Inc.: SWOT Analysis
231    ICU Medical Inc.: Overall Product Portfolio
232    ICU Medical Inc.: Product Portfolio of Drug Infusion Systems
233    ICU Medical Inc.: Overall Financials (2014-2016)
234    ICU Medical Inc.: Revenue by Segment (2014-2016)
235    ICU Medical Inc.: Revenue by Sub-Segment (2014-2016)
236    ICU Medical Inc.: Global Presence
237    ICU Medical Inc.: SWOT Analysis
238    IRADIMED CORPORATION: Product Portfolio of Drug Infusion Systems
239    IRADIMED CORPORATION: Overall Financials (2014-2016)
240    IRADIMED CORPORATION: Revenue by Region (2014-2016)
241    IRADIMED CORPORATION: Revenue by Business Segment (2015-2017)
242    IRADIMED CORPORATION: Global Presence
243    IRADIMED CORPORATION:SWOT Analysis
244    Insulet Corporation: Overall Product Portfolio
245    Insulet Corporation: Product Portfolio of Drug Infusion Systems
246    Insulet Corporation: Overall Financials (2014-2016)
247    Insulet Corporation: Revenue by Region (2014-2016)
248    Insulet Corporation: Revenue by Business Segment (2014-2016)
249    Insulet Corporation: Global Presence
250    Insulet Corporation: SWOT Analysis
251    Medtronic Public Limited Company: Overall Product Portfolio
252    Medtronic Public Limited Company: Product Portfolio of Drug Infusion Systems
253    Medtronic Public Limited Company: Overall Financials (2015-2017)
254    Medtronic Public Limited Company: Net Revenue by Region (2015-2017)
255    Medtronic Public Limited Company: Revenue by Business Segment (2015-2017)
256    Medtronic Public Limited Company: Revenue by Sub-Segment (2015-2017)
257    Medtronic Public Limited Company: Global Presence
258    Medtronic Public Limited Company: SWOT Analysis
259    MOOG, Inc.: Overall Product Portfolio
260    MOOG, Inc.: Product Portfolio of Drug Infusion Systems
261    MOOG, Inc.: Overall Financials (2015-2017)
262    MOOG, Inc.: Revenue by Segment (2015-2017)
263    MOOG, Inc.: Global Presence
264    MOOG, Inc. SWOT Analysis
265    Smiths Group plc: Overall Product Portfolio
266    Smiths Group plc: Product Portfolio of Drug Infusion Systems
267    Smiths Group plc: Overall Financials (2015-2017)
268    Smiths Group plc: Net Revenue by Region (2015-2016)
269    Smiths Group plc: Net Revenue by Region, 2017
270    Smiths Group plc: Revenue by Division (2015-2017)
271    Smiths Group plc.: Revenue By Smiths Medical Sub-division (2015-2017)
272    Smiths Group plc.: Global Presence
273    Smiths Group plc SWOT Analysis
274    Tandem Diabetes Care, Inc.: Overall Product Portfolio
275    Tandem Diabetes Care, Inc.: Products Under Development
276    Tandem Diabetes Care: Overall Financials (2014-2016)
277    Tandem Diabetes Care: Global Presence
278    Tandem Diabetes Care, Inc.: SWOT Analysis
279    Terumo Corporation: Overall Product Portfolio
280    Terumo Corporation: Product Portfolio of Drug Infusion Systems
281    Terumo Corporation: Overall Financials (2015-2017)
282    Terumo Corporation: Net Revenue by Region (2015-2017)
283    Terumo Corporation: Revenue by Business Segment (2015-2017)
284    Terumo Corporation: Revenue by Sub-Segment (2015-2017)
285    Terumo Corporation: Global Presence
286    Terumo Corporation: SWOT Analysis
287    Zyno Medical, LLC: Overall Product Portfolio
288    Zyno Medical, LLC: Product Portfolio of Drug Infusion Systems
289    Zyno Medical, LLC: SWOT Analysis
290    Global Infusion Systems Market Segmentation 
291    Data Triangulation

Table
of Contents

Request a Sample

Global Drug Infusion Systems Market

Focus on Products, Application, Competitive Landscape and 57 Countries - Analysis and Forecast (2017-2025)